• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Acorda Therapeutics Inc

+ Add to Watchlist

ACOR:US

32.2900 USD 0.2900 0.89%

As of 12:26:00 ET on 09/02/2014.

Snapshot for Acorda Therapeutics Inc (ACOR)

Open: 32.8700 Day's Range: 32.2500 - 33.1000 Volume: 109,548
Previous Close: 32.5800 52wk Range: 27.5100 - 39.9450 1-Yr Rtn: -4.35%

Stock Chart for ACOR

No chart data available.
  • ACOR:US 32.3200
  • 1D
  • 1M
  • 1Y
32.5800
Interactive ACOR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACOR

Current P/E Ratio (ttm) 70.3924
Estimated P/E(12/2014) 33.0972
Relative P/E vs. SPX 3.8773
Earnings Per Share (USD) (ttm) 0.4645
Est. EPS (USD) (12/2014) 0.9880
Est. PEG Ratio 0.7355
Market Cap (M USD) 1,365.06
Shares Outstanding (M) 41.74
30 Day Average Volume 416,724
Price/Book (mrq) 2.6529
Price/Sale (ttm) 3.7086
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACOR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ACOR

Acorda Therapeutics Inc. is a biotechnology company that is developing therapies for spinal cord injury and related neurological conditions, including multiple sclerosis. Additionally, Acorda is developing multiple approaches to regeneration and repair of the spinal cord and brain.

Ron CohenPresident/CEO/FounderMichael W RogersChief Financial Officer
Andrew HindmanChief Business Development OfcrEnrique J CarrazanaChief Medical Officer
More Company Profile & Key Executives for ACOR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil